The President’s Cancer Panel (PCP) is demanding that federal and state authorities spend more resources into ensuring that children are inoculated with the human papillomavirus virus vaccine to prevent reproductive cancer development.
HPV vaccine manufacturers GlaxoSmithKline Merck are expecting profit surges because of their products: Cervix and Gardasil.
Currently, estimates assume that a 3rd of teenage girls have been exposed to the HPV vaccines available, while only 7% of boys have received the inoculation.
Barbara Rimer, chair of the PCP said : “We are confident that if HPV vaccination for girls and boys is made a public health priority, hundreds of thousands will be protected from these HPV-associated diseases and cancers over their lifetimes.”
Young men are being targeted for HPV as the Centers for Disease Control and Prevention (CDC) says is correlated with the development of genital warts; as well as cancer of the throat, tonsils, base of the tongue, anus and penis
Join us on our
Share this page with your friends
on your favorite social network: